AMD's next-gen CDNA 3 architecture will be the first exascale APU design, packing both CPU and GPU chiplets on the same package. AMD has promised an insane 5x or higher (AI) performance-per-watt ...
CareDx (CDNA) has been beaten down lately with too much selling pressure. While the stock has lost 22.5% over the past four weeks, there is light at the end of the tunnel as it is now in oversold ...
For the quarter ended December 2025, CareDx (CDNA) reported revenue of $108.39 million, up 25.2% over the same period last year. EPS came in at $0.12, compared to $0.18 in the year-ago quarter. The ...
In a unanimous decision last month, the Supreme Court ruled that naturally occurring genes are not patentable. But, said the Court, cDNA, a man-made copy of the genetic messenger in cells, is ...
Back in 2020, AMD announced it was splitting its post-GCN architecture into RDNA for gaming, with CDNA for its data center GPUs, with CDNA later being the architecture of its Radeon Instinct AI ...
Investors in CareDx Inc (Symbol: CDNA) saw new options begin trading this week, for the February 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...
AMD gave us a glimpse of its future this week, divulging new information about its Radeon and Ryzen roadmaps during the company’s Financial Analyst Day. Lots of new information was disseminated, but ...
CareDx (CDNA) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.03 per share a year ago. These figures are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results